ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021
August 02 2021 - 7:30AM
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the
Company's second quarter 2021 financial results will be released
after market close on Monday, August 9, 2021. ChemoCentryx
executive management will host a conference call and webcast
beginning at 5:00 p.m. Eastern Time on August 9, 2021 to discuss
these results and to answer questions.
To participate by telephone, please dial (877) 303-8028
(Domestic) or (760) 536-5167 (International). The conference ID
number is 2164528. A live and archived audio webcast can be
accessed through the Investors section of the Company's website at
www.ChemoCentryx.com. The archived webcast will remain available on
the Company's website for fourteen (14) days following the
call.
About ChemoCentryx ChemoCentryx is a
biopharmaceutical company developing new medications for
inflammatory and autoimmune diseases and cancer. ChemoCentryx
targets the chemokine and chemoattractant systems to discover,
develop and commercialize orally-administered therapies.
ChemoCentryx’s lead drug candidate, avacopan (CCX168), successfully
completed a pivotal Phase III trial in ANCA-associated vasculitis
and is in late stage clinical development for the treatment of
severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G).
ChemoCentryx also has early stage drug candidates that target
chemoattractant receptors in other inflammatory and autoimmune
diseases and in cancer.
Contacts:
Susan M. KanayaExecutive Vice President,Chief
Financial and Administrative Officerinvestor@chemocentryx.com
Media:Stephanie
Tomei408.234.1279media@chemocentryx.com
Investors:Lee Roth, Burns
McClellan212.213.0006lroth@burnsmc.com
ChemoCentryx (NASDAQ:CCXI)
Historical Stock Chart
From Apr 2024 to May 2024
ChemoCentryx (NASDAQ:CCXI)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about ChemoCentryx Inc (NASDAQ): 0 recent articles
More News Articles